We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings. Learn more about our Privacy Notice... [opens in a new tab]
This community is part of Research Directions - a journal collection based around cutting edge research questions.

Lyme Disease Experience Survey 2024 - NICE Guideline 95 Insights

03 April 2025, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.
This item is a response to a research question in One Health
Q. What is the current and expected evolution of prevalence, geographical spread and impact of ticks and tick-borne diseases, and what strategies are needed to improve management, testing, diagnosis and treatment of these diseases amongst patients and animal populations?

Abstract

Little is formally documented on the lived experience of Lyme disease - the state of diagnosis, treatment and care and the impact of the lives of those infected. Lyme Resource Centre conducted an online survey to gather information on the impact of Lyme disease in the United Kingdom and Republic of Ireland. This poster explores application of key aspects of NICE Guideline 95 recommendations on diagnosis and treatment of Lyme disease for the United Kingdom.

Keywords

Lyme disease
Patient experience
Tick-borne disease
Public health
NICE Guideline

Supplementary materials

Title
Description
Actions
Title
Supplementary Material - Lyme Disease Experience Survey - NICE Guideline 95 Insights
Description
Supplementary Material includes the survey questions used and methodology behind question selection.
Actions

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.